- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 31.03. | IMAC Holdings, Inc. - 15-12G, Securities registration termination | 3 | SEC Filings | ||
| 19.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 19.03. | Aditxt beruft Jeff Busch an die Spitze der Tochtergesellschaft Ignite Proteomics | 1 | Investing.com Deutsch | ||
| 19.03. | Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary | 2 | Investing.com | ||
| 13.03. | Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down | 1 | Seeking Alpha | ||
| 13.03. | Aditxt acquires precision oncology firm Ignite Proteomics | 2 | Investing.com | ||
| 13.03. | Aditxt übernimmt Präzisionsonkologie-Unternehmen Ignite Proteomics | 2 | Investing.com Deutsch | ||
| 27.02. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.02. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.12.25 | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.12.25 | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.09.25 | IMAC Holdings, Inc.: Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers | 226 | GlobeNewswire (Europe) | The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,850 | +6,01 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 7,080 | +0,71 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,740 | 0,00 % | IMUNON announces $10M cash financing | ||
| ROCKWELL MEDICAL | 0,585 | +1,74 % | H.C. Wainwright reiterates Rockwell Medical stock rating on contract wins | ||
| VIRIDIAN THERAPEUTICS | 13,600 | 0,00 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| SINTX TECHNOLOGIES | 2,110 | +3,94 % | SINTX Technologies prices $4.5M private placement as part of $5M capital raise | ||
| AETHLON MEDICAL | 1,940 | +1,57 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| NEURONETICS | 1,240 | +10,22 % | Neuronetics Appoints Robert Greene as Senior Vice President Sales | MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd.: StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 15-12G, Securities registration termination | ||
| HVIVO | 0,088 | +1,16 % | hVIVO schließt Beratungsvertrag mit Decoy Therapeutics | ||
| FRESENIUS | 37,260 | +1,61 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.06.2026 / 13:38... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 34,840 | +0,55 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen |
Das Unternehmen IMAC HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.